Surmodics (SRDX) Earnings Date, Estimates & Call Transcripts $30.75 +0.14 (+0.46%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$30.73 -0.02 (-0.07%) As of 03/28/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Surmodics Latest Earnings SummaryUpcoming Q2 Earnings DateApr. 29Before Market OpensEstimatedActual EPS (Feb. 6) -$0.04 Beat By $0.04 Consensus EPS (Feb. 6) -$0.08 Surmodics posted Q1 2025 earnings on February 6, 2025, reporting an EPS of -$0.04, which topped analysts' consensus estimates of -$0.08 by $0.04. With a trailing EPS of -$1.01, Surmodics' earnings are expected to grow 300.00% next year, from $0.20 to $0.80 per share. SRDX Upcoming EarningsSurmodics' next earnings date is estimated for Tuesday, April 29, 2025, based off prior year's reporting schedules. Get Surmodics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Surmodics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSRDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SRDX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Surmodics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20252-$0.11-$0.09-$0.10 Q2 20252-$0.04$0.00-$0.02 Q3 20252$0.08$0.08$0.08 Q4 20252$0.17$0.18$0.18 FY 20258$0.10$0.17$0.14 Q1 20261$0.21$0.21$0.21 Q2 20261$0.22$0.22$0.22 Q3 20261$0.16$0.16$0.16 Q4 20261$0.18$0.18$0.18 FY 20264$0.77$0.77$0.77 Q1 20271$0.20$0.20$0.20 Remove Ads Surmodics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/29/2025(Estimated)-------2/6/2025Q1 2025-$0.08-$0.04+$0.04-$0.26$33.37M-11/6/2024--$0.27-$0.13+$0.14-$0.02$30.69M$33.23M7/31/2024Q3 2024-$0.31-$0.27+$0.04-$0.01$30.32M$30.34M5/1/2024Q2 2024-$0.36$0.07+$0.43$0.12$28.79M$31.96M11/8/2023Q4 2023$0.16$0.53+$0.37$0.59$26.00M$27.97M8/2/2023Q3 2023-$0.46$0.52+$0.98$0.52$26.70M$52.48M4/26/2023Q2 2023-$0.49-$0.40+$0.09-$0.25$25.99M$27.20M Surmodics Earnings - Frequently Asked Questions When is Surmodics's earnings date? Surmodics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 29th, 2025 based off last year's report dates. Learn more on SRDX's earnings history. Did Surmodics beat their earnings estimates last quarter? In the previous quarter, Surmodics (NASDAQ:SRDX) reported ($0.04) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.08) by $0.04. Learn more on analysts' earnings estimate vs. SRDX's actual earnings. How much revenue does Surmodics generate each year? Surmodics (NASDAQ:SRDX) has a recorded annual revenue of $125.45 million. How much profit does Surmodics generate each year? Surmodics (NASDAQ:SRDX) has a recorded net income of -$11.54 million. SRDX has generated -$1.01 earnings per share over the last four quarters. What is Surmodics's EPS forecast for next year? Surmodics's earnings are expected to grow from $0.20 per share to $0.80 per share in the next year, which is a 300.00% increase. More Earnings Resources from MarketBeat Related Companies AtriCure Earnings Results Alphatec Earnings Results Orthofix Medical Earnings Results AngioDynamics Earnings Results Accuray Earnings Results Rockwell Medical Earnings Results ReShape Lifesciences Earnings Results Abbott Laboratories Earnings Results Intuitive Surgical Earnings Results Boston Scientific Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss Remove Ads This page (NASDAQ:SRDX) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
